MELISSA COLLINS: Open Payments
NPI 1689422396 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$164 in 7 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $164
Food & beverage: $164
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $60 |
| Neurocrine BioSciences, Inc. | 2 | $49 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: VRAYLAR, INGREZZA, Auvelity, REXULTI.
Industry payments across DE — which companies pay providers there.
